Fundamentals Hub
▼ FY 2026 Summary Analysis
Annual report ending Mar 31, 2026Overview and Growth
Fiscal 2026 results for VivoSim Labs, INC. combined $131.00K of revenue with net loss of $13.84M and an operating cash outflow of $10.83M. Revenue of $131.00K sets the scale for evaluating how effectively sales translated into profit and cash during the year. Revenue was 9.0% below fiscal 2025 revenue of $144.00K, marking a top-line contraction. Diluted earnings per share were -$5.35, translating the period’s attributable earnings into the amount reported for each diluted share. The diluted weighted-average share count was 2.59M, linking total earnings with the per-share result received by shareholders. Compared with 1.46M diluted shares in fiscal 2025, the current 2.59M base was 76.8% higher. Total assets stood at $7.39M, showing the scale of resources supporting revenue, earnings, liquidity, and financing. Revenue equaled 0.02x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.Profitability
The first profit layer was $131.00K of gross profit, the amount available after reported direct revenue costs to absorb operating expenses. Gross profit represented 100.0% of revenue, showing how much of the top line remained after direct costs. The company recorded an operating loss of $11.49M after the reported operating expense base. The bottom-line result was a net loss of $13.84M after operating, financing, tax, and other recognized items. The company reported negative EBITDA of $11.27M, adding a pre-interest, tax, depreciation, and amortization view of the operating shortfall. The company reported a pretax loss of $13.84M, before the effect of income taxes. Income tax expense totaled $2.00K, providing the reported tax component that separates pretax and after-tax earnings. The loss-to-assets relationship was 187.4%, placing the bottom-line deficit against the company’s resource base. Compared with a $2.49M net loss in fiscal 2025, the current loss increased to $13.84M.Liquidity and Capital Structure
At period end, the $7.39M asset base was financed through $8.48M of liabilities and -$1.10M of equity. Equity was negative at -$1.10M, meaning liabilities exceeded the residual book value available to shareholders and weakening balance-sheet resilience. Current assets were $6.63M against $2.79M of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. Current assets covered current liabilities by 2.38x, leaving a positive buffer for near-term obligations. The company held $5.02M in cash and equivalents, a narrower liquidity measure than total current assets. The cash balance equaled 180.4% of current liabilities, showing how much near-term coverage came from cash alone. Equity equaled -14.9% of assets, showing the shareholder-capital layer within the company’s balance sheet. The liabilities-to-assets relationship was 114.9%, placing reported obligations against the full positive asset balance. Cash and equivalents equaled 68.0% of total assets, showing the liquid cash component within the company’s broader resource base. Compared with $14.65M in fiscal 2025, the current asset base moved 49.6% and finished lower. Against $10.49M of equity in fiscal 2025, the current book-equity balance moved 110.5% and ended lower. Compared with $11.31M in fiscal 2025, the current cash balance moved 55.6% and finished lower.Cash Flow and Earnings Quality
Operating activities used $10.83M of cash, resulting in an operating cash outflow for the year. Negative free cash flow was $10.83M, leaving a cash deficit after capital spending and reducing financial flexibility. The free-cash-flow deficit equaled 146.6% of total assets, placing the cash shortfall against the company’s resource base. Cash absorbed by operations increased from $9.46M in fiscal 2025 to $10.83M.
Based on the annual report for the fiscal year ending Mar 31, 2026.
Analysis generated .